Skip to main content

ADVISORY/ HTS Biosystems & Applied Biosystems to Present Research on Next-Generation Protein Affinity Array Technology at IBC's Annual International Conference on Antibody Engineering.


 
Who/What:            New research on HTS Biosystems' and Applied 
                     Biosystems' proprietary biomolecular kinetic 
                     analysis technology will be presented at IBC Life 
                     Sciences' 13th Annual International Conference on 
                     Antibody Engineering (December 1-4, 2002). This 
                     next-generation microarray-based SPR (surface 
                     plasmon resonsance) system is designed to help 
                     researchers profile and characterize biomolecular 
                     interactions in a parallel format, while 
                     decreasing costs associated with this productive 
                     type of quantitative analysis. 
 
                     Highlights: 
 
                     -    Early access users of the technology, the 
                          University of Utah and Dyax Corp., will 
                          present their preliminary utility experience 
                          with the system. 
 
                     -    Demonstrations of the technology's user 
                          interface will be offered at the Applied 
                          Biosystems booth at the conference. 
 
Why:                 -    The Antibody Engineering Meeting will 
                          enable HTS Biosystems and Applied Biosystems 
                          to showcase their progress in the 
                          development of advanced, label-free SPR 
                          array technology designed to accelerate drug 
                          discovery R&D with higher throughput, 
                          content-rich biomolecular binding 
                          characterization screening. 
 
 
 
Where:               Paradise Point Resort 
                     1404 Vacation Road 
                     San Diego, CA 92109 
 
When:                The oral research presentations include: 
 
                     -    Sunday, December 1, 1:40 p.m. (PST): 
                          Affinity Biosensing to the nth Degree 
                          (Dr. David Myszka, Center for Biomolecular 
                          Interaction Analysis, University of Utah) 
 
                     -    Monday, December 2, 4:30 p.m. (PST): 
                          A Microarray-Based Surface Plasmon Resonance 
                          Method For the Rapid Determination of Phage 
                          Display Derived Human Antibody Dissociation 
                          Constants 
                          (Dr. Dan Sexton, Investigator, Dyax 
                          Corporation) 
 
                     Data from the abstracts are embargoed to the 
                     press until after each presentation. For more 
                     information, or to obtain a copy of the abstract, 
                     please visit: 
                     http://www.lifesciencesinfo.com/antibodyeng 
 
 
About HTS            HTS Biosystems, Inc. is a privately held 
Biosystems:          biotechnology company specializing in 
                     high-throughput bioanalytical systems for the 
                     rapidly growing field of proteomics. HTS 
                     Biosystems offers a unique portfolio of 
                     innovative technologies that support all phases 
                     of proteomics, from discovery to development of 
                     therapeutic and diagnostic products. The 
                     company's technology platform - the 
                     Proteomatrix(TM) Solution - streamlines the 
                     discovery process and captures fixed costs for 
                     more effective use of protein data in target 
                     screening, validation, and discovery efforts. 
                     Collaborations with key industry partners, such 
                     as Applied Biosystems, Dyax Corporation, 
                     Mitsubishi Chemical Corporation, and Molsoft LLC 
                     have driven the development of the company's 
                     technologies and related systems, including the 
                     joint HTS Biosystems-Applied Biosystems 
                     next-generation SPR array technology platform, 
                     the CHEMI FLEX(TM) System, and the PHASE FLEX(TM) 
                     System for target discovery, screening and 
                     validation. HTS Biosystems' operations are 
                     located in Hopkinton, MA. For more information, 
                     visit www.htsbiosystems.com 
 
About Applied        Applied Biosystems, a business unit of Applera 
Biosystems:          Corporation, develops and markets 
                     instrument-based systems, reagents, software, and 
                     contract related services to the life science 
                     industry and research community. These 
                     technologies enable biological discoveries in 
                     life science research, pharmaceutical research 
                     and development, diagnostics, and agriculture. 
                     Its broad portfolio of technologies, which 
                     includes DNA sequencing, PCR, organic synthesis, 
                     chemiluminescence, mass spectrometry, and 
                     information management systems, enable genomics, 
                     proteomics, high throughput screening, and other 
                     molecular analyses. For more information, visit: 
                     http://www.appliedbiosystems.com 

Comments

Popular posts from this blog

ATG Announces Gross Proceeds of $100.6 Million.

ATG (Art Technology Group Inc., NASDAQ: ARTG) announced that the underwriters of its public offering exercised their option to purchase an additional 3,750,000 shares of common stock to cover over-allotments. Deutsche Bank Securities Inc. and Morgan Stanley & Co. Inc. are acting as joint book-running managers and underwriters for the offering. On Friday, February 5th, ATG announced a public follow-on offering of 25,000,000 shares of its common stock at $3.50 per share. Taking into account the full exercise of the option to purchase additional shares, total gross proceeds are expected to be approximately $100.6 million. The offering is expected to close on February 10, 2010. ATG filed a shelf registration statement on Form S-3 relating to the securities described above with the Securities and Exchange Commission on November 2, 2009, which became effective on November 18, 2009. This press release does not constitute an offer to sell or a solicitation of an offer to buy th...

Orange Business Services Named a Leader for Managed Global MPLS Services, According to Independent Research Firm.

Orange Business Services is named a leader in The Forrester Wave™: Managed Global MPLS Services, Q4 20091, published in October 2009 by Forrester Research Inc., an independent research firm. Forrester evaluated the strengths and weaknesses of the providers across 54 criteria in three main categories: current offering, strategy and market presence. In assessing the highest score of Orange Business Services in current offering, Forrester stated: "Orange has the broadest global MPLS service portfolio, the most comprehensive and widely available access choices, and received very high scores for network performance. It tied with [another vendor] for the very strong operations support systems and processes supporting managed MPLS and with [two vendors] for the quality of its NOC technical staff. It also received high customer satisfaction feedback, got very high scores for its go-to-market strategy, and high scores for service pricing, global sales and technical su...

Viacom Puts HTS Network on the Block

  Viacom Inc. said yesterday that it will sell Home Team Sports, the valuable Washington regional sports cable television network, as part of the $91 billion merger of Viacom and CBS. Viacom Inc. said it will combine CBS Cable and MTV Networks as part of the deal but has no desire to own several parts of CBS Cable, including HTS; the Midwest Sports Channel, which serves Minneapolis and Milwaukee; or the advertising services firm Group W Sports Marketing. Viacom started to look for an HTS buyer even before the merger was finalized, MTV spokeswoman Carole Robinson said, adding that there are "several interested buyers," which she declined to name. CBS Cable owns 66 percent of Bethesda-based HTS, with the other 34 percent held by Fox Sports Net, which is assembling a group of regional cable sports networks throughout the United States and would be one logical purchaser. Robinson, CBS Cable spokeswoman Cheryl Daly and Jody Shapiro, a senior vice president of CBS Cabl...